Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°
Per-Encounter Medical Market, By Product Type, By Application, By Distribution Channel, By Geography
»óǰÄÚµå
:
1741511
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀåÀº 2025³â¿¡´Â 1,562¾ï 5,000¸¸ ´Þ·¯, 2032³â¿¡´Â 4,416¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â¿¡ °ÉÃÄ CAGR 16%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
º¸°í ¹üÀ§ |
º¸°í¼ ¼¼ºÎÁ¤º¸ |
±âÁØ ¿¬µµ |
2024³â |
2025³â ½ÃÀå ±Ô¸ð |
1,562¾ï 5,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2020-2024³â |
¿¹Ãø ±â°£ |
2025-2032³â |
¿¹Ãø ±â°£ : 2025-2032³â CAGR : |
16.00% |
2032³â °¡Ä¡ ¿¹Ãø |
4,416¾ï ´Þ·¯ |
Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º´Â ±âÁ¸ÀÇ ÇÇÆ÷ ¼ºñ½º ¸ðµ¨ÀÌ ¾Æ´Ñ ¹æ¹®´ç Á¦°øµÇ´Â ÀÇ·á ¼ºñ½ºÀÔ´Ï´Ù.
¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀåÀº ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ :
¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀåÀº ¸î °¡Áö ÃËÁø¿äÀο¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·áºñ »ó½ÂÀ¸·Î ÀÎÇØ ȯÀÚµéÀº °æÁ¦ÀûÀ¸·Î ½ÇÇà °¡´ÉÇÑ ´ëü Ä¡·á ¿É¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¸¼º Áúȯ Áõ°¡³ª °í·Éȵµ, ⱸ ÀÇ·á ¼ºñ½º ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. Cancer Facts &Figures' º¸°í¼¿¡ µû¸£¸é ¹Ì±¹¿¡¼´Â ¾à 190¸¸¸íÀÌ »õ·Ó°Ô ¾ÏÀ¸·Î Áø´ÜµÇ¾úÀ¸¸ç 60¸¸9,360¸íÀÌ »ç¸ÁÇÑ °ÍÀ¸·Î º¸°íµÇ¾ú½À´Ï´Ù.
±×·¯³ª ½ÃÀå¿¡ ¾ïÁ¦¿äÀεµ ÀÖ½À´Ï´Ù. º¸Çè »óȯ Á¤Ã¥ÀÇ ºÎÁ·°ú Ç¥ÁØÈµÈ ±ÔÁ¦¿Í Á¤Ã¥ÀÇ ºÎÀç´Â Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸Çϰí Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå¿¡´Â ÃæºÐÇÑ ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ ±â¼úÀ» ÅëÇØ ÀÇ·á Á¦°øÀÚ´Â ¼Ò¿ÜµÈ Áö¿ª¿¡ µµ´ÞÇÏ¿© °¡»óÀ¸·Î ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇÔÀ¸·Î½á Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½ºÀÇ ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- º» º¸°í¼¿¡¼´Â ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ¿¬µµ·Î¼, 2025³âºÎÅÍ 2032³â±îÁöÀÇ ¿¹Ãø ±â°£¿¡ ÀÖ¾î¼ ½ÃÀå ±Ô¸ð ¹× CAGRÀ» Á¦°øÇÕ´Ï´Ù.
- ¶Ç, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÇô, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ¼ ÇØ¼³Çß½À´Ï´Ù.
- ¶Ç ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã³ª ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.
- º» º¸°í¼¿¡¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±Ù°ÅÇØ ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½ºÀå¿¡ ÀÖ¾î¼ÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
- º» º¸°í¼·ÎºÎÅÍÀÇ ÅëÂû¿¡ ÀÇÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ³ª ±â¾÷ÀÇ °æ¿µÁøÀº Àå·¡ÀÇ Á¦Ç° ¹ß¸Å, À¯Çü ¾÷, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.
- ÀÌ Á¶»ç º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.
- ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
- º¸°í¼ ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½Â
- ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç
- ½ÅÈï ½ÃÀå È®´ë
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ±ÔÁ¦ ½Ã³ª¸®¿À
- ÃÖ±Ù µ¿Çâ
- Á¦Ç° Ãâ½Ã/½ÂÀÎ
- PEST ºÐ¼®
- PORTER ºÐ¼®
- ÇÕº´, Àμö ¹× Á¦ÈÞ
Á¦4Àå ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå, Äڷγª ¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ
- COVID-19 ¿ªÇÐ
- °ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
- °æÁ¦¿¡ ¹ÌÄ¡´Â ¿µÇâ
Á¦5Àå ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå, Á¦Ç° À¯Çüº°, 2020³â-2032³â
- ¼Ò¸ðǰ
- µð¹ÙÀ̽º
- ¼ÒÇÁÆ®¿þ¾î
- ¼ºñ½º
- ±âŸ
Á¦6Àå ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå, ¿ëµµº°, 2020³â-2032³â
- ½ÉÀ庴ÇÐ
- Á¤Çü¿Ü°ú
- »êºÎÀΰú
- ¾È°ú
- ¼Òȱ⳻°ú
- ±âŸ
Á¦7Àå ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå, À¯Åë ä³Îº°, 2020³â-2032³â
- Á÷Á¢ ÆÇ¸Å
- ¼Ò¸Å ¸ÅÃâ
- ¿Â¶óÀÎ ÆÇ¸Å
Á¦8Àå ¼¼°èÀÇ Áø·á ´ÜÀ§Çü ÀÇ·á ¼ºñ½º ½ÃÀå, Áö¿ªº°, 2020³â-2032³â
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ASEAN
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- GCC ±¹°¡
- À̽º¶ó¿¤
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«
- Áß¾Ó ¾ÆÇÁ¸®Ä«
- ºÏ¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
- ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Catalent Inc.
- Smiths Medical Inc.
- Cardinal Health
- Schott
- Nipro Corporation
- Terumo Corporation
- Gerresheimer AG
- Becton, Dickinson and Company
- Braun Melsungen AG
- AngioDynamics Inc.
- Teleflex Incorporated
- Argon Medical Devices, Inc.
- ICU Medical, Inc.
- Medical Components, Inc.
- Vygon(UK) Ltd
Á¦10Àå ¼½¼Ç
- Âü°í¹®Çå
- Á¶»ç ¹æ¹ý
- ÃâÆÇ»ç¿¡ ´ëÇØ
SHW
¿µ¹® ¸ñÂ÷
Per-Encounter Medical Market is estimated to be valued at USD 156.25 Bn in 2025 and is expected to reach USD 441.6 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16% from 2025 to 2032.
Report Coverage |
Report Details |
Base Year: |
2024 |
Market Size in 2025: |
USD 156.25 Bn |
Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: |
16.00% |
2032 Value Projection: |
USD 441.6 Bn |
Per-encounter medical services refer to medical treatments provided on a per-visit basis, rather than the traditional fee-for-service model. This approach is revolutionizing the healthcare landscape by offering more cost-effective and convenient care options for patients.
Global per-encounter medical market is experiencing considerable growth due to various factors. Patients are increasingly seeking more affordable healthcare options, and per-encounter medical services provide an attractive alternative. Advancements in technology have made it possible to deliver high-quality care remotely, further driving the demand for per-encounter medical services.
Market Dynamics:
Global per-encounter medical market is propelled by several drivers. Firstly, the rising healthcare costs are prompting patients to seek alternative care options that are economically viable. Per-encounter medical services offer transparent pricing and allow patients to pay only for the services they need, thus making healthcare more accessible. Moreover, the increasing prevalence of chronic diseases and the aging population further contribute to the demand for per-encounter medical services. Increasing prevalence of diseases such as cancer and end stage renal disease, which require longer duration therapies (dialysis and chemotherapy) is expected to drive the market growth. For instance, in January 2022according to data published in the Cancer Facts & Figures report by the American Cancer Society, , around 1.9 million new cancer cases was estimated to be diagnosed and 609,360 cancer deaths were reported in the U.S.
However, the market also has restraints. Lack of reimbursement policies and the absence of standardized regulations can hinder the growth of the per-encounter medical market. There may be concerns regarding the quality and continuity of care, as per-encounter medical services focus more on episodic care rather than comprehensive medical management.
Despite these challenges, the per-encounter medical market presents ample opportunities. The growing adoption of telemedicine and remote monitoring technologies provide a potential avenue for expansion. These technologies enable healthcare providers to reach underserved areas and offer healthcare services virtually, thereby fostering the growth of per-encounter medical services. Furthermore, collaborations between healthcare providers and insurance companies can help address reimbursement concerns and drive market growth.
Key features of the study:
- This report provides in-depth analysis of the global per-encounter medical market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global per-encounter medical market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., and Vygon (UK) Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global per-encounter medical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global per-encounter medical market
Detailed Segmentation:
- Global Per-Encounter Medical Market, By Product Type
- Consumables
- Devices
- Software
- Services
- Others
- Global Per-Encounter Medical Market, By Application
- Cardiology
- Orthopedics
- Obstetrics/Gynecology
- Ophthalmology
- Gastroenterology
- Others
- Global Per-Encounter Medical Market, By Distribution Channel
- Direct Tender
- Retail Sales
- Online Sales
- Global Per-Encounter Medical Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles
- Catalent Inc.
- Smiths Medical Inc.
- Cardinal Health
- Schott
- Nipro Corporation
- Terumo Corporation
- Gerresheimer AG
- Becton, Dickinson and Company
- B.Braun Melsungen AG
- AngioDynamics Inc.
- Teleflex Incorporated
- Argon Medical Devices, Inc.
- ICU Medical, Inc.
- Medical Components, Inc.
- Vygon (UK) Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising prevalence of chronic diseases
- Stringent regulatory requirements
- Emerging markets expansion
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Per-Encounter Medical Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Per-Encounter Medical Market, By Product Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Per-Encounter Medical Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Orthopedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Obstetrics/Gynecology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Per-Encounter Medical Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Direct Tender
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Online Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Per-Encounter Medical Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Company Profile
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Argon Medical Devices, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- References
- Research Methodology
- About us
°ü·ÃÀÚ·á